Australia markets close in 1 hour 56 minutes

Trinity Biotech plc (TRIB)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
1.4100+0.0100 (+0.71%)
At close: 04:00PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
86,147
92,965
101,980
90,435
97,035
Cost of revenue
51,713
54,888
53,400
52,315
55,586
Gross profit
34,434
38,077
48,580
38,120
41,449
Operating expenses
Research development
4,025
4,497
5,080
5,325
5,369
Selling general and administrative
24,417
24,683
25,074
30,335
26,652
Total operating expenses
23,774
24,512
28,294
37,940
34,747
Operating income or loss
10,660
13,565
20,286
180
6,702
Interest expense
6,493
5,459
6,751
6,582
5,080
Total other income/expenses net
-
-6,940
-20,204
-24,292
-26,929
Income before tax
-3,189
751
-6,633
-29,997
-23,183
Income tax expense
-433
-178
-620
-1,006
-525
Income from continuing operations
-2,756
929
-6,013
-28,991
-22,658
Net income
-13,006
875
-6,388
-28,914
-22,090
Net income available to common shareholders
-13,006
875
-6,388
-28,914
-22,090
Basic EPS
-
0.04
-0.32
-1.40
-1.06
Diluted EPS
-
0.04
-0.32
-1.40
-1.06
Basic average shares
-
20,902
20,902
20,902
20,903
Diluted average shares
-
26,630
26,256
25,468
25,877
EBITDA
-
8,954
3,195
-18,521
-13,982